IOVS 2027
Diabetic eye disease remains a significant clinical and public-health challenge and is a major cause of vision impairment worldwide. Ongoing research is advancing our understanding of retinal vascular damage, inflammation, neurodegeneration, and the mechanisms underlying disease onset and progression. Emerging technologies, including artificial intelligence, advanced retinal imaging, and digital screening platforms, are creating new opportunities for earlier detection, risk assessment, and continuous disease monitoring. At the same time, novel pharmacological, biological, and targeted therapeutic approaches are being investigated to improve visual outcomes and reduce treatment burden. This session will provide a multidisciplinary platform to discuss advances in the prevention, diagnosis, monitoring, and management of diabetic retinopathy and diabetic macular edema, while highlighting emerging research and future directions in diabetic eye care.
- AI & Automated Screening for Diabetic Retinopathy
- Diabetic Macular Edema: Emerging Therapies
- Retinal Imaging & Biomarkers in Diabetes
- Novel Pharmacological & Gene-Based Therapies
- Prevention, Early Detection & Personalized Management
Related Sessions
Tags
Diabetic Retinopathy Conferences
- Diabetic Retinopathy Meetings
- World Congress on Diabetic Retinopathy
- Diabetic Retinopathy Events
- Diabetic Retinopathy Summit
- Diabetic Retinopathy Symposium
- Diabetic Retinopathy Seminars
- Diabetic Retinopathy Workshops
- Diabetic Retinopathy Congress
- Hybrid Event on Diabetic Retinopathy
- Upcoming Event on Diabetic Retinopathy
- Diabetic Retinopathy Global Online Event
- Diabetic Retinopathy Session
- International Conference on Diabetic Retinopathy
- Global Conference on Diabetic Eye Disease